AML only.
RC110 was also awarded Rare Paediatric Disease (RPD) status which entitled RAC to a Priority Review Voucher (PRV) upon registration. These PRV's are worth ~US$100m
https://www.pharmaceutical-technology.com/features/switching-sales-investigating-the-financial-impacts-of-fdas-priority-vouchers/?cf-view
Any word on RPD status @RaceOncology?
- Forums
- ASX - By Stock
- RAC
- Ann: US FDA Orphan Drug Designation Awarded to RC220 Bisantrene
Ann: US FDA Orphan Drug Designation Awarded to RC220 Bisantrene, page-27
-
-
- There are more pages in this discussion • 84 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.59 |
Change
0.020(1.27%) |
Mkt cap ! $270.9M |
Open | High | Low | Value | Volume |
$1.59 | $1.62 | $1.57 | $131.5K | 82.97K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7804 | $1.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.59 | 3041 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7804 | 1.585 |
3 | 7300 | 1.575 |
2 | 22134 | 1.570 |
2 | 2550 | 1.565 |
1 | 7500 | 1.560 |
Price($) | Vol. | No. |
---|---|---|
1.590 | 3041 | 1 |
1.595 | 290 | 1 |
1.600 | 6850 | 2 |
1.605 | 446 | 1 |
1.610 | 1021 | 2 |
Last trade - 12.35pm 16/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |